Physicians' experiences, attitudes, and beliefs towards medical cannabis: a systematic literature review.

Publisher: BioMed Central Country of Publication: England NLM ID: 100967792 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-2296 (Electronic) Linking ISSN: 14712296 NLM ISO Abbreviation: BMC Fam Pract Subsets: MEDLINE

Original Publication: London : BioMed Central, [2000-2021]

General Practitioners* ; Medical Marijuana*/therapeutic use; Attitude of Health Personnel ; Humans ; Practice Patterns, Physicians' ; Qualitative Research

Background: An increasing number of countries legalise the use of medical cannabis or allow it for a narrow range of medical conditions. Physicians, and often the patients' general practitioner, play a major role in implementing this policy. Many of them, however, perceive a lack of evidence-based knowledge and are not confident with providing patients with medical cannabis. The objectives of this review are to synthesise findings about hospital physicians' and GPs' experiences, attitudes, and beliefs towards the use of medical cannabis with the purpose of identifying barriers and facilitators towards providing it to their patients.
Methods: Peer-reviewed articles addressing hospital physicians' and GPs' experiences, attitudes, and beliefs towards the use of medical cannabis were searched systematically in PubMed, Scopus, EMBASE, and the Cochrane Library.
Results: Twenty-one articles were included from five different countries in which the medical cannabis laws varied. The studied physicians experienced frequent inquiries about medical cannabis from their patients (49-95%), and between 10 and 95% of the physicians were willing to prescribe and/or provide it to the patients, depending on setting, specialty and experience among the physicians. This review found that physicians experienced in prescribing medical cannabis were more convinced of its benefits and less worried about adverse effects than non-experienced physicians. However, physicians specialized in addiction treatment and certain relevant indication areas seemed more sceptical compared to physicians in general. Nevertheless, physicians generally experienced a lack of knowledge of clinical effects including both beneficial and adverse effects.
Conclusion: This review indicates that GPs and hospital physicians from various specialties frequently experience patient demands for medical cannabis and to some degree show openness to using it, although there was a wide gap between studies in terms of willingness to provide. Hospital physicians and GPs' experienced in prescribing are more convinced of effects and less worried of adverse effects. However, most physicians experience a lack of knowledge of beneficial effects, adverse effects and of how to advise patients, which may comprise barriers towards prescribing. More research, including larger studies with cohort designs and qualitative studies, is needed to further examine facilitators and barriers to physicians' prescribing practices.
(© 2021. The Author(s).)

BMJ Open. 2017 Dec 21;7(12):e019851. (PMID: 29273671)
Mov Disord Clin Pract. 2016 May 20;4(1):90-95. (PMID: 30713951)
J Pain Res. 2018 Jul 31;11:1411-1419. (PMID: 30104896)
BMC Fam Pract. 2019 Jan 22;20(1):17. (PMID: 30669979)
J Addict Dis. 2005;24(3):87-93. (PMID: 16186085)
J Thorac Oncol. 2018 Apr;13(4):480-487. (PMID: 29374567)
Schmerz. 2016 Feb;30(1):3-13. (PMID: 26767992)
Epilepsy Behav. 2017 May;70(Pt B):288-291. (PMID: 28169144)
Harm Reduct J. 2015 Oct 14;12:46. (PMID: 26467203)
Isr Med Assoc J. 2015 Jul;17(7):437-41. (PMID: 26357721)
Addiction. 2012 May;107(5):875-6. (PMID: 22471567)
Rambam Maimonides Med J. 2016 Apr 19;7(2):. (PMID: 27101219)
J Pediatr Nurs. 2004 Dec;19(6):385-92. (PMID: 15637579)
J Drugs Dermatol. 2018 Dec 01;17(12):1273-1278. (PMID: 30586258)
BMJ Open. 2018 Jul 3;8(7):e022101. (PMID: 29970456)
Braz J Psychiatry. 2006 Jun;28(2):153-7. (PMID: 16810401)
BMC Musculoskelet Disord. 2014 Jul 30;15:258. (PMID: 25080153)
J Pain. 2016 Jun;17(6):654-68. (PMID: 26961090)
J Clin Oncol. 2018 Jul 1;36(19):1957-1962. (PMID: 29746226)
J Am Board Fam Med. 2013 Jan-Feb;26(1):52-60. (PMID: 23288281)
J Pain Res. 2016 Sep 30;9:735-744. (PMID: 27757048)
Cannabis Cannabinoid Res. 2018 Mar 01;3(1):74-84. (PMID: 29662957)
Epilepsia. 2015 Jan;56(1):1-6. (PMID: 25413126)
J Psychoactive Drugs. 2018 Sep-Oct;50(4):348-354. (PMID: 29714640)
CMAJ Open. 2015 Apr 02;3(2):E251-7. (PMID: 26389104)
PLoS One. 2019 May 6;14(5):e0216556. (PMID: 31059531)
Soc Work Public Health. 2014;29(2):121-31. (PMID: 24405197)
Int J Drug Policy. 2018 Jul;57:4-10. (PMID: 29653439)
BMJ. 2009 Jul 21;339:b2535. (PMID: 19622551)
BMC Med Educ. 2015 Mar 19;15:52. (PMID: 25888752)
Harm Reduct J. 2017 Jan 13;14(1):4. (PMID: 28086792)
J Law Med. 2006 Aug;14(1):135-42. (PMID: 16937787)

Keywords: Attitudes; Barriers; Experiences; Facilitators; Medical cannabis; Physicians

0 (Medical Marijuana)

Date Created: 20211022 Date Completed: 20211101 Latest Revision: 20211101

20231215

PMC8532330

10.1186/s12875-021-01559-w

34674661